This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MEDNAX Expands Further in Florida With Radiology Affiliation
by Zacks Equity Research
MEDNAX (MD) forms an association with Boca Radiology Group to strengthen its radiology business in Florida.
Community Health Divests Hospitals to Reduce Debt Level
by Zacks Equity Research
Community Health (CYH) continues to divest hospitals to focus on core operations and reduce debt burden.
Should Value Investors Buy HCA Holdings (HCA) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will Select Medical's Solid Run in 2019 Sustain in 2020?
by Zacks Equity Research
Acquisitions, partnerships and growth in admissions to drive Select Medical's (SEM) performance in 2020.
Community Health Lags Industry YTD: Will it Reverse in 2020?
by Zacks Equity Research
Backed by lower expenses, debt repayment and business streamlining, Community Health (CYH) holds enough potential to grow in 2020.
Pick These 5 Stocks With Superb Interest Coverage Ratio
by Sumit Singh
Interest coverage ratio is used to determine how effectively a company can pay the interest charged on its debt.
MEDNAX (MD) Catches Eye: Stock Jumps 8.1%
by Zacks Equity Research
MEDNAX (MD) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
6 Trade-Proof Sector ETFs to Follow if No Deal is Cracked
by Sanghamitra Saha
These sector ETFs are almost trade-resistant and thus unlikely to suffer if no deal is cracked before Dec 15.
These 5 Stocks Sport Impressive Interest Coverage Ratio
by Sumit Singh
Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.
HCA (HCA) Up 3.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why is HCA Healthcare an Attractive Stock for Your Portfolio?
by Zacks Equity Research
Growing revenues and a strong capital position bode well for HCA Healthcare (HCA).
HCA (HCA) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
HCA (HCA) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Healthcare Stocks in Focus on Price Transparency Rule
by Sapna Bagaria
Hospital stocks gain from a less-than-expected strict price transparency rule and health insurers' optimism on a likely rise in profitability from a low-cost plan.
US Equities Continue to March Steadily Higher
by David Borun
Positive developments in international trade and healthcare puch stocks to another round of new record highs.
Is HCA Healthcare (HCA) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (HCA) Outperforming Other Medical Stocks This Year?
MEDNAX's Ratings Get Affirmed by Moody's, Outlook Negative
by Zacks Equity Research
MEDNAX (MD) receives rating affirmations from Moody's. However, the outlook is changed to negative.
Is HCA Holdings (HCA) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Stocks That Stand Out on Attractive Interest Coverage Ratio
by Sumit Singh
Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.
Looking for Value? Why It Might Be Time to Try HCA Healthcare (HCA)
by Zacks Equity Research
HCA Healthcare (HCA) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
More Record Highs in a Broadly Positive Week for US Equities
by David Borun
Easing of trade concerns and a steepening yield curve supporting steady share appreciation
HCA (HCA) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
HCA (HCA) possesses solid growth attributes, which could help it handily outperform the market.
Can Segmental Growth Aid Hologic (HOLX) in Q4 Earnings?
by Zacks Equity Research
Developments in Breast Health and Molecular Diagnostics businesses are likely to have aided Hologic's (HOLX) performance in fourth-quarter fiscal 2019.
HCA Healthcare (HCA) Catches Eye: Stock Jumps 6.4%
by Zacks Equity Research
HCA Healthcare (HCA) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
HCA Healthcare (HCA) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter results gain traction from better revenues.
HCA Holdings (HCA) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 4.21% and 1.55%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?